Advertisement
Life-Sciences-Europe.com
The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Novo Nordisk to Acquire Cardior for up to €1.025b (2024-03-25)
Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is... - Tricares Appoints Ahmed Elmouelhi as CEO (2024-03-25)
TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO). In conjunction with this, a... - Angelini Ventures Adds €7m to Series C of Nouscom (2024-03-21)
> Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing round > Financing will enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinic... - Mirador Therapeutics Emerges with over $400m in Financing (2024-03-21)
> Rapidly advancing multiple therapeutic programs leveraging Mirador360 TM precision development engine incorporating advances in human genetics and cutting-edge data science > Company led by several former executives of Prometheus Biosciences and founded by cha... - Cure51 Raises €15m Seed Round Led by Sofinnova Partners (2024-03-20)
> Fundraise led by Sofinnova Partners, with participation from Hitachi Ventures GmbH, Life Extension Ventures, Xavier Niel, and Olivier Pomel, CEO, and co-founder of Datadog > Principal investigators included world-renowned oncology centers such as Gustave Rouss... - Engrail Therapeutics Closes Oversubscribed $157m Series B (2024-03-19)
Proceeds to Support Advancement of Engrail’s Pipeline for Neuropsychiatric and Neurodevelopmental Disorder Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to improve t... - Medios to Acquire Ceban Pharma for €259.2m in Cash & Shares (2024-03-18)
Important first step in building the leading European Specialty Pharma platform – Mid-term targets to be reached already in 2025 Medios, the leading provider of Specialty Pharma Solutions in Germany, today announced the acquisition of Ceban Pharmaceuticals B... - Bico Founders Leave to Signal Clear Cut from Past Practice (2024-03-15)
Following discussions with the board, the company's founders Erik Gatenholm and Hector Martinez are leaving BICO after eight years. "I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the ch... - Tubulis Closes €128m Series B2 & to Establish US Subsidiary (2024-03-14)
> Financing round co-led by EQT Life Sciences and Nextech Invest¹, with participation from current and new leading global biotechnology investors > Proceeds will support clinical evaluation of lead solid tumor ADC candidates, TUB-030 and TUB-040, further techn... - Alithea Genomics Closes CHF 2.8m Seed Financing Extension (2024-03-14)
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a C...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top